StockDriftsStockDriftsTop 1 Two Sigma Ventures, Lp Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS IN | 100% | 903.4K | $10K | — | — | — | 2022-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Two Sigma Ventures, Lp reports $9.61K in US-listed equity holdings across 1 position in its most recent 13F filing. Its largest disclosed position is RXRX (100.0%). Figures reflect the Q3 2022 filing.
Sign up free to track Two Sigma Ventures, Lp, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Two Sigma Ventures, Lp’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1878979). View Two Sigma Ventures, Lp’s 13F filings on SEC